Business

Health Care Buzz Today

1 Mins read

Social Media Shows Promise for Clinical Trials. Social media can be used to increase enrollment and reduce clinical trial delays, according to a new survey by Blue Chip Patient Recruitment.

Social Media Shows Promise for Clinical Trials. Social media can be used to increase enrollment and reduce clinical trial delays, according to a new survey by Blue Chip Patient Recruitment.

ACSM Releases New Exercise Guidelines. The new guidelines by the American College of Sports Medicine aren’t all that different from their old ones, except they emphasize that sitting for long periods is a health risk that can’t be negated simply by exercising regularly.

Spine Journal Takes Aim at Infuse Research. The Spine Journal is devoting an entire issue to critical reviews of published studies of Medtronic’s bone morphogenetic protein-2 product known as Infuse (see Pizaazz coverage of the matter here).

Google+ Begins Limited Field Testing. The company’s top secret social layer supposedly turns the search engine into a giant social network. It’s the culmination of a year-long project, and amounts to Google’s answer to Facebook.

Social Media Being Used as a Platform to Disclose Illness. The Internet has not only transformed how consumers gain access to health information, it is also significantly changing how they seek comfort during a health crisis, according to new research from Russell Herder. 

Related posts
Business

Improving Safety in the Workplace: Drone Inspections

3 Mins read
One health-related issue that people don’t think about enough is workplace safety. We previously talked about some steps that can be taken…
Business

4 Things You Need To Know Before Launching A Health Restaurant

4 Mins read
Health restaurants are rapidly gaining popularity across the globe, with customers becoming more and more body-conscious. With global obesity reaching a record…
Business

Why Are the Shares of Major Vaccine Producers Plummeting?

2 Mins read
Given the success of the coronavirus vaccine rollout in countries such as the UK and Israel, you could be forgiven for thinking…